# Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy

> **NCT05536596** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Universitat Internacional de Catalunya** · enrollment: 220 (estimated)

## Conditions studied

- Retrognathism
- Prognathism
- Orthognathic Surgery
- Neurosensory Disorder

## Interventions

- **PROCEDURE:** Orthognathic Surgery
- **DRUG:** Melatonin 10 MG Oral Tablet
- **DRUG:** Hydroxycobalamin
- **DRUG:** Centrum

## Key facts

- **NCT ID:** NCT05536596
- **Lead sponsor:** Universitat Internacional de Catalunya
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2022-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536596, "Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05536596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*